AVE Science & Technology Co

AVE Science & Technology Co Capital Intensity

The Capital Intensity Ratio of AVE Science & Technology Co (688067.SS) as of Nov 16, 2026 is 252.20 %. In the previous year, Capital Intensity Ratio was 275.92 % — a change of -8.60% (lower).

Capital Intensity

252.20 %

YoY

-8.60%

Last updated:

Capital Intensity Ratio of AVE Science & Technology Co is 2025 252.20 % . Capital Intensity Ratio of AVE Science & Technology Co was 2024 275.92 % . It decreases by -8.60% lower compared to the previous year.

The AVE Science & Technology Co Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2018
171.16 CNY
Jan 1, 2019
156.56 CNY
Jan 1, 2020
164.58 CNY
Jan 1, 2021
259.94 CNY
Jan 1, 2022
279.33 CNY
Jan 1, 2023
277.92 CNY
Jan 1, 2024
275.92 CNY
Jan 1, 2025
252.20 CNY
The AVE Science & Technology Co Capital Intensity history
YEARCapital IntensityYoY
252.20 %-8.60%
275.92 %-0.72%
277.92 %-0.51%
279.33 %+7.46%
259.94 %+57.94%
164.58 %+5.12%
156.56 %-8.53%
171.16 %+3.60%
165.21 %-8.51%
180.58 %+0.31%
180.03 %-10.89%
202.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Capital Intensity Ratio of AVE Science & Technology Co is 252.20 % in 2025.

Capital Intensity Ratio of AVE Science & Technology Co changed from 275.92 % to 252.20 %, representing a -8.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's AVE Science & Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co